Top news of June: Zero-emission vehicles, mandibular advancement device for OSA
Healio has compiled the most-read news in pulmonology posted in June.
Highlights include a report discussing the public health benefits of switching to zero-emission vehicles; a study that found improvement in obstructive sleep apnea with mandibular advancement device therapy; a Q&A on how to protect patients with respiratory diseases during a wildfire outbreak; a study that demonstrated less lung function decline with a plant-centered diet; an FDA approval for generic tiotropium bromide inhalation powder; and more.
Read these and other top stories in pulmonology below:
Q&A: Benefits of switching to zero-emission vehicles, ways to achieve health equity
With more public health benefits and fewer deaths as a result of switching to zero-emission passenger vehicles, the American Lung Association is calling on the EPA to set stronger emission rules, according to a press release. Read more.
‘High efficacy’ with mandibular advancement device in new moderate to severe OSA
For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference. Read more.
Q&A: Protecting patients with respiratory diseases during wildfire outbreak
People residing in the East Coast are currently experiencing poor air quality due to smoke and haze from hundreds of wildfires in Canada. Read more.
Plant-centered diet consumption linked to less lung function decline
Annual lung function decline rates were lower in individuals who had high adherence to a plant-centered diet, according to an abstract presented at the American Thoracic Society International Conference. Read more.
FDA approves generic tiotropium bromide inhalation powder
The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release. Read more.
Q&A: Test rapidly determines sepsis probability in patients in emergency department
A test designed to rapidly determine sepsis probability in ED patients suspected of having an infection was found to be reliable, according to an abstract presented at the American Thoracic Society International Conference. Read more.
Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis
In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation. Read more.
Improved survival in intubated patients with COVID-19 with longer prone positioning
Prolonged prone position ventilation for 24 hours or more was linked to less death at 30 and 90 days in COVID-19 patients on mechanical ventilation, according to study results published in CHEST. Read more.
Monitoring advised for children, teens with Down syndrome using positive airway pressure
Positive airway pressure device compliance went down 90 days after a clinic visit among patients with Down syndrome, according to an abstract presented at the American Thoracic Society International Conference. Read more.
FDA grants 510(k) clearance to pulse oximeter device for infants
The FDA has granted 510(k) clearance to a prescription pulse oximeter in the form of a sock for monitoring oxygen saturation levels of infants, according to a manufacturer-issued press release. Read more.